Trotabresib
Trotabresib (CC-90010) is an orally bioavailable BET bromodomain inhibitor for research use. It has demonstrated activity in preclinical studies of advanced solid tumors, showing antitumor effects in both in vitro cellular assays and in vivo animal models.
Product Specifications
CAS Number
1706738-98-8
Product Name Alternative
Trotabresib, CC 90010, CC90010, CC-90010, BET, Epigenetic Reader Domain, EpigeneticReaderDomain
Field of Research
Epigenetics & Chromatin
Purity
99.03% (May vary between batches)
Solubility
DMSO:45 mg/mL (117.35 mM) ;10% DMSO+90% Corn Oil:2 mg/mL (5.22 mM)
Smiles
Cn1cc (-c2cc (ccc2OCC2CC2) S (C) (=O) =O) c2ccccc2c1=O
Molecular Formula
C21H21NO4S
Molecular Weight
383.46
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS8509317-02 0.1 mL (AF635)
NF-kappaB p105/p50 (phospho-Ser927) Antibody
Sign In for Pricing
View Details MBS8509317-03 0.1 mL (AF610)
NF-kappaB p105/p50 (phospho-Ser927) Antibody
Sign In for Pricing
View Details MBS8509317-04 0.1 mL (AF405S)
NF-kappaB p105/p50 (phospho-Ser927) Antibody
Sign In for Pricing
View Details MBS8509317-05 0.1 mL (AF405L)
NF-kappaB p105/p50 (phospho-Ser927) Antibody
Sign In for Pricing
View Details